Agent- 86
Your guess on this is as good as mine because I really don’t know.
All I can offer is a couple of observations.
Firstly, as I think I’ve said before, if NNZ-2591 is successful in Phase 2 PMD, I think it unlikely that Neuren will be running a Phase 3 trial in PMD or any other indication. My feeling is that, whether we like it or not, it will be Acadia running the show.
That said, I believe that Neuren will continue to work towards making NNZ-2591 a Phase 3-ready asset by completing all the necessary manufacturing requirements (very important step) and meeting with the FDA (and possibly EMA) in a post-Phase 2 meeting to ascertain what the FDA’s pivotal trial requirements are. With respect to trial design, I think that any potential acquirer would prefer to control that.
The clinical trials website suggests that there has been just one Phase 3 trial commenced in PMD, which is still in progress – and that’s a randomized, double-blind placebo-controlled 12 week treatment trial in 7-18 yr olds with PMD and ASD, using a pre-existing drug (lithium). There appears to be just one recruitment site in Paris, and they are aiming to enrol just 22 patients and expect that to take 2 years.
Other current Phase 2 trials in PMD are small (in a couple of cases, just 6 participants) and recruiting at just one or two sites.
However, I’d expect any Phase 3 trial of NNZ-2591 in PMD to be considerably larger than the current Phase 2, where all 20 participants are receiving the drug.
- Forums
- ASX - By Stock
- NEU
- Phelan-McDermid Syndrome
Phelan-McDermid Syndrome, page-72
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$15.57 |
Change
-0.040(0.26%) |
Mkt cap ! $1.990B |
Open | High | Low | Value | Volume |
$15.83 | $15.87 | $15.20 | $8.124M | 524.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 64 | $15.49 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.58 | 597 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 64 | 15.490 |
2 | 1474 | 15.480 |
1 | 8454 | 15.460 |
1 | 1808 | 15.440 |
2 | 2028 | 15.400 |
Price($) | Vol. | No. |
---|---|---|
15.580 | 597 | 1 |
15.590 | 1867 | 2 |
15.600 | 602 | 2 |
15.610 | 506 | 1 |
15.620 | 1108 | 1 |
Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |